Omega Fund Management’s Nuvation Bio NUVB Stock Holding History
Bought
Maintained
Sold
Other funds holding NUVB
DC
VCM
LCM
DFO
RG
Omega Fund Management's NUVB Position: Q1 2026 in Review
Omega Fund Management held its Nuvation Bio (NUVB) position steady in Q1 2026 at 8,081,089 shares worth $34.7M. The position accounts for 21.25% of the portfolio, ranked #2.
Omega Fund Management first reported a position in NUVB in Q1 2021 and has held it in 21 quarters since. The position peaked at $295M in Q1 2021. 231 funds tracked by Wall St. Rank hold NUVB as of Q1 2026.
- Omega Fund Management held 8,081,089 shares of Nuvation Bio worth $34.7M as of Q1 2026.
- Omega Fund Management left its Nuvation Bio share count unchanged in Q1 2026.
- Nuvation Bio made up 21.25% of Omega Fund Management's portfolio in Q1 2026, its #2 holding.
- Omega Fund Management first reported a position in Nuvation Bio in Q1 2021 and has held it in 21 quarters since.
- Omega Fund Management's Nuvation Bio position peaked at $295M in Q1 2021.
- 231 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2026.
Based on Omega Fund Management's 13F filing for Q1 2026, filed 15 May 2026.